Lenzilumab in hospitalised patients with COVID-19 pneumonia (LIVE-AIR): a phase 3, randomised, placebo-controlled trial

LIVE-AIR Study Group

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Lenzilumab in hospitalised patients with COVID-19 pneumonia (LIVE-AIR): a phase 3, randomised, placebo-controlled trial'. Together they form a unique fingerprint.

Medicine & Life Sciences